Cloud P. Paweletz

Also affiliated with Dana-Farber Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 29 papers. Top paper: “Targeting TBK1 to overcome resistance to cancer immunotherapy”.

Targeting TBK1 to overcome resistance to cancer immunotherapy

Nature(2023)10.1038/s41586-023-05704-6

N/A

4.0DataRank · unranked

171 citations

Or‐Yam Revach, Seth Anderson, Emily Kessler, Clara Wolfe, Anne Jenney +54 more

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade

Journal of Clinical Investigation(2020)10.1172/jci135038

N/A

1.9DataRank · unranked

75 citations

Andrew Portell, Elena V. Ivanova, Patrick H. Lizotte, Navin R. Mahadevan, Jonathan Greene +23 more

Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9507

N/A

1.5DataRank · unranked

39 citations

Daniel B. Costa, Cloud P. Paweletz, Mark M. Awad, Paul Marcoux, Deepa Rangachari +13 more

Tumor-Derived cGAMP Regulates Activation of the Vasculature

Frontiers in Immunology(2020)10.3389/fimmu.2020.02090

N/A

0DataRank · unranked

61 citations

Shriram K. Sundararaman, Sarah E. Shelton, Erik H. Knelson, Navin R. Mahadevan, Ryohei Yoshida +15 more

Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-4084

N/A

0DataRank · unranked

45 citations

Ryan D. Gentzler, Sarah Clifford, Jill Kolesar, Alona Muzikansky, Eric B. Haura +15 more

Traditional Diagnostics versus Disruptive Technology: The Role of the Pathologist in the Era of Liquid Biopsy

Cancer Research(2020)10.1158/0008-5472.can-20-0134

N/A

0DataRank · unranked

10 citations

Geoffrey R. Oxnard, Cloud P. Paweletz, Lynette M. Sholl

Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non–Small Cell Lung Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1844

N/A

0DataRank · unranked

42 citations

Mari Kuraguchi, Man Xu, Andrew Portell, Luke J. Taus, Irmina Diala +17 more

Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0913

N/A

0DataRank · unranked

219 citations

Erik H. Knelson, Jacquelyn O. Wolff, Amir Vajdi, Maria Saigí, Marco Campisi +38 more

Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions

Genome biology(2021)10.1186/s13059-021-02315-0

N/A

0DataRank · unranked

40 citations

Dan Li, Rebecca Kusko, Natalia Novoradovskaya, Yifan Zhang, Shangzi Wang +95 more

Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC

JCO Precision Oncology(2021)10.1200/po.20.00419

N/A

0DataRank · unranked

29 citations

Christie J. Lau, Marina S.D. Milan, Julianna Supplee, Jonathan W. Riess, Penelope A. Bradbury +4 more

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health

JCO Precision Oncology(2021)10.1200/po.20.00528

N/A

0DataRank · unranked

21 citations

Thomas Forbes, Steven P. Lund, Kenneth D. Cole, Hua‐Jun He, Chris Karlovich +12 more

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Cancer Cell(2022)10.1016/j.ccell.2022.08.015

N/A

0DataRank · unranked

102 citations

Tetsuo Tani, Benjamin F. Springer, Marco Campisi, Tatsuya Osaki, Koji Haratani +23 more

Activation of Tumor-Cell STING Primes NK-Cell Therapy

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0017

N/A

0DataRank · unranked

89 citations

Elena V. Ivanova, Mubin Tarannum, Marco Campisi, Patrick H. Lizotte, Matthew A. Booker +44 more

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-0770

N/A

0DataRank · unranked

39 citations

Maria Saigí, Tetsuo Tani, Benjamin F. Springer, Hirofumi Shibata, Shunsuke Kitajima +19 more

Osimertinib plus necitumumab in EGFR-mutant NSCLC: Final results from an ETCTN California Cancer Consortium phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9014

N/A

0DataRank · unranked

11 citations

Mark Krailo, Sukhmani K. Padda, Susan Groshen, Heather A. Wakelee, Karen L. Reckamp +14 more

503 Cytotoxic revival is implicated in response to neoadjuvant PD-1 blockade for head and neck squamous cell carcinoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0503

N/A

0DataRank · unranked

2 citations

Giacomo Oliveira, Ann Marie Egloff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou +33 more

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Science Immunology(2023)10.1126/sciimmunol.adf4968

N/A

0DataRank · unranked

118 citations

Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock +34 more

Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.12.019

N/A

0DataRank · unranked

24 citations

Maisam Makarem, Mizuki Nishino, S. Emily Bachert, Tom Zhang, Jaclyn LoPiccolo +11 more

Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0795

N/A

0DataRank · unranked

23 citations

Grace A. Heavey, Yanan Kuang, Emily Durlacher, Thian Kheoh, Richard C. Chao +10 more

Data from MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

(2023)10.1158/0008-5472.c.6514215.v1

N/A

0DataRank · unranked

0 citations

Maria Saigí, Tetsuo Tani, Benjamin F. Springer, Hirofumi Shibata, Shunsuke Kitajima +19 more

Data from MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

(2023)10.1158/0008-5472.c.6514215

N/A

0DataRank · unranked

0 citations

Maria Saigí, Tetsuo Tani, Benjamin F. Springer, Hirofumi Shibata, Shunsuke Kitajima +19 more

Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3477

N/A

0DataRank · unranked

15 citations

Michihisa Kono, Hoang C.B. Nguyen, Ann Marie Egloff, Cameron Messier, Patrick H. Lizotte +4 more

Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae615

N/A

0DataRank · unranked

8 citations

Jacobo Buelvas Mebarak, John C Magnotto, George A. Stamatiades, Yanan Kuang, Cloud P. Paweletz +13 more

Round-Robin Comparison of RET Rearrangement Detection in ctDNA: A Novel Method for Limited Clinical Samples

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3747

N/A

0DataRank · unranked

3 citations

Alison M. Urvalek, Minh Ha, Kavita S. Garg, Aimee Bence Lin, Anna M. Szpurka +4 more

Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102198

N/A

0DataRank · unranked

4 citations

Zehua Li, Jessica Ritter, Elliott J. Brea, Navin R. Mahadevan, Deborah Dillon +17 more

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia

Cancer Cell(2020)10.1016/j.ccell.2020.10.010

N/A

0DataRank · unranked

177 citations

Marissa S. Pioso, Elyse A. Olesinski, Binyam Yilma, Jeremy Ryan, Thelma Mashaka +18 more

Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials

JCO Precision Oncology(2025)10.1200/po-25-00245

N/A

0DataRank · unranked

0 citations

Thomas Forbes, Laura M. Yee, Grace A. Heavey, Hua‐Jun He, Zhiyong He +35 more

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

Cancer Cell(2020)10.1016/j.ccell.2019.12.006

N/A

0DataRank · unranked

476 citations

Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi +39 more

Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3608

N/A

0DataRank · unranked

220 citations

Magda Bahcall, Liam F. Spurr, Jianwei Che, Biagio Ricciuti, Giulia C. Leonardi +18 more